Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center Feasibility Study of Intranasal Insulin in Frontotemporal Dementia NIFT-D

NCT04115384 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT04115384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04115384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center Feasibility Study of Intranasal Insulin in Frontotemporal Dementia NIFT-D
Lead sponsor
HealthPartners Institute
Phase
Phase 2
Overall status
Terminated
Start date
September 9, 2019
Completion date
May 15, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frontotemporal dementia, behavioral variant